Association between plasma exosome neurogranin and brain structure in patients with Alzheimer’s disease: a protocol study
Introduction Neurogranin is known to be significantly elevated in patients with Alzheimer’s disease (AD) and may be an effective clinical predictor of cognitive decline and neurodegeneration. Amnestic mild cognitive impairment (aMCI) is an intermediate disease state between normal cognitive ageing a...
Saved in:
| Main Authors: | Ping Liu, Zheng Xu, Lin Tan, MengFei He, Li Sun, Wenhui Cao, Changhao Yin, Wenqiang Sun, Weina Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/8/e036990.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2016-08-01) -
Neurogranin in Alzheimer's Disease: Roles in synaptic function, pathology, and potential as a diagnostic biomarker
by: Rajkumar Bavaharini, et al.
Published: (2024-09-01) -
Interactions between calmodulin and neurogranin govern the dynamics of CaMKII as a leaky integrator.
by: Mariam Ordyan, et al.
Published: (2020-07-01) -
Plasma biomarkers of brain atrophy in Alzheimer's disease.
by: Madhav Thambisetty, et al.
Published: (2011-01-01) -
Plasma exosomal miRNA expression and gut microbiota dysbiosis are associated with cognitive impairment in Alzheimer’s disease
by: Kaihao Lin, et al.
Published: (2025-02-01)